HSBC Holdings
TEVA icon

HSBC Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

HSBC Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,700
Closed -$335K – 3217
2025
Q4 		$335K Sell
10,700
-177,900
-94% -$4.38M ﹤0.01% 2480
2025
Q3 		$3.81M Buy
188,600
+54,500
+41% +$957K ﹤0.01% 1282
2025
Q2 		$2.25M Sell
134,100
-54,500
-29% -$879K ﹤0.01% 1442
2025
Q1 		$2.91M Buy
+188,600
New +$3.37M ﹤0.01% 1308
2019
Q2 		– Sell
-5,500
Closed -$86K – 2853
2019
Q1 		$86K Buy
+5,500
New +$97K ﹤0.01% 2635
2018
Q3 		– Sell
-179,700
Closed -$4.37M – 2654
2018
Q2 		$4.37M Buy
+179,700
New +$3.66M 0.01% 1185
2017
Q4 		– Sell
-300
Closed -$5K – 2360
2017
Q3 		$5K Sell
300
-2,700
-90% -$60.8K ﹤0.01% 2287
2017
Q2 		$100K Buy
3,000
+900
+43% +$27.9K ﹤0.01% 2130
2017
Q1 		$69K Hold
2,100
– – ﹤0.01% 2075
2016
Q4 		$76K Sell
2,100
-1,400
-40% -$55.9K ﹤0.01% 2643
2016
Q3 		$161K Buy
+3,500
New +$183K ﹤0.01% 1965
2014
Q3 		– Sell
-6,000
Closed -$317K – 1793
2014
Q2 		$317K Sell
6,000
-5,000
-45% -$256K ﹤0.01% 1591
2014
Q1 		$581K Buy
+11,000
New +$508K ﹤0.01% 1364

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HSBC Holdings's TEVA Position: Q1 2026 in Review

HSBC Holdings increased its Teva Pharmaceuticals (TEVA) stake by 57% in Q1 2026, buying an estimated $11.3M and bringing the position to 961,140 shares worth $28.8M. The position accounts for 0.02% of the portfolio, ranked #653.

HSBC Holdings first reported a position in TEVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $29.9M in Q3 2025. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • HSBC Holdings held 961,140 shares of Teva Pharmaceuticals worth $28.8M as of Q1 2026.
  • HSBC Holdings bought 350,534 Teva Pharmaceuticals shares in Q1 2026, an estimated $11.3M.
  • Teva Pharmaceuticals made up 0.02% of HSBC Holdings's portfolio in Q1 2026, its #653 holding.
  • HSBC Holdings first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • HSBC Holdings's Teva Pharmaceuticals position peaked at $29.9M in Q3 2025.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.